A judge has approved a bid by group members to discontinue a class action alleging pharmacy giant Priceline exercised an “overly prescriptive level of control” on franchisees which limited their profitability, saying it was unlikely to succeed with a litigation funder.
Subscribe for instant access to all Lawyerly content.
